Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 2 diabetes currently treated with basal insulin (QWINT-3): a phase 3, randomised, non-inferiority trial
Eli Lilly and Company
Athena Philis-Tsimikas; Richard M Bergenstal; Timothy S Bailey; Hideaki Jinnouchi; James R Thrasher; Liza Ilag; Jit Mitra; Kristen Syring; Rebecca J Threlkeld